Table 1.
Population | Time point for collection | ||||
NDH | Overweight/obese | Baseline | 6 months | 12 months | |
Primary Outcome | HbA1c Weight |
Weight | X | X | X |
Secondary outcomes | |||||
Intervention factors | |||||
Amount of human support planned and delivered (coaching, phone calls, emails). | X | X | X | X | |
Numbers referred | X | X | X | X | X |
Numbers registered | X | X | X | X | X |
Numbers who start to use the intervention | X | X | X | X | X |
Numbers who complete the intervention | X | X | X | X | X |
Usage data for each user | X | X | X | X | X |
Friends and Families Test | X | X | X | X | |
Behavioural and clinical outcomes | |||||
Height for calculation of BMI | X | X | X | ||
Physical activity (IPAQ) | X | X | X | X | X |
Patient activation (PAM-13). | X | X | X | X | X |
Economic outcomes | |||||
Cost of the digital diabetes prevention intervention | X | X | X | ||
Types of staff involved in implementation in each LHE | X | X | X | X | X |
Time spent by each member of staff on implementation of the DDPP (estimated) | X | X | X | X | X |
Additional costs | X | X | X | X | X |
BMI, body mass index; DDPP, digital diabetes prevention programme; HbA1c, glycated haemoglobin; IPAQ, International Physical Activity Questionnaire; LHE, local health economies; NDH, non-diabetic hyperglycaemia; PAM-13, 13-tem Patient Activation Measure.